Quarterly report · Q2

Period2023-04-01 → 2023-09-30
Filed2023-11-09
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 61
MetricValuePeriodScopeSource row
Revenue¥436.6bn2023-04-01 → 2023-09-30Cons.Revenue IFRS (5-year summary)
Revenue¥228.9bn2023-07-01 → 2023-09-30dCons.Revenue IFRS (5-year summary)
Revenue¥881.9bn2022-04-01 → 2023-03-31Cons.Revenue IFRS (5-year summary)
Revenue¥417.1bn2022-04-01 → 2022-09-30Cons.Revenue IFRS (5-year summary)
Revenue¥224.8bn2022-07-01 → 2022-09-30dCons.Revenue IFRS (5-year summary)
Operating income¥4.8bn2023-04-01 → 2023-09-30Cons.Operating profit loss IFRS
Operating income−¥17.7bn2023-07-01 → 2023-09-30dCons.Operating profit loss IFRS
Operating income¥93.6bn2022-04-01 → 2022-09-30Cons.Operating profit loss IFRS
Operating income¥49.1bn2022-07-01 → 2022-09-30dCons.Operating profit loss IFRS
Profit before tax−¥958m2023-04-01 → 2023-09-30Cons.Profit loss before tax IFRS
Profit before tax−¥20.7bn2023-07-01 → 2023-09-30dCons.Profit loss before tax IFRS
Profit before tax¥182.3bn2022-04-01 → 2023-03-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥89.3bn2022-04-01 → 2022-09-30Cons.Profit loss before tax IFRS
Profit before tax¥47.3bn2022-07-01 → 2022-09-30dCons.Profit loss before tax IFRS
Net income (owners)¥216.3bn2023-04-01 → 2023-09-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)−¥24.3bn2023-07-01 → 2023-09-30dCons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥143.4bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥66.8bn2022-04-01 → 2022-09-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥42.0bn2022-07-01 → 2022-09-30dCons.Profit loss attributable to owners of parent IFRS
Net income¥216.7bn2023-04-01 → 2023-09-30Cons.Profit loss IFRS
Net income−¥24.0bn2023-07-01 → 2023-09-30dCons.Profit loss IFRS
Net income¥66.9bn2022-04-01 → 2022-09-30Cons.Profit loss IFRS
Net income¥42.0bn2022-07-01 → 2022-09-30dCons.Profit loss IFRS
Total assets¥1.62Tat 2023-09-30Cons.Assets IFRS
Total assets¥1.51Tat 2023-03-31Cons.Assets IFRS
Total assets¥1.49Tat 2022-09-30Cons.Total assets IFRS (5-year summary)
Total liabilities¥790.2bnat 2023-09-30Cons.Liabilities IFRS
Total liabilities¥867.1bnat 2023-03-31Cons.Liabilities IFRS
Net assets / equity¥827.5bnat 2023-09-30Cons.Equity IFRS
Net assets / equity¥641.2bnat 2023-03-31Cons.Equity IFRS
Net assets / equity¥644.1bnat 2022-09-30Cons.Equity IFRS
Net assets / equity¥511.4bnat 2022-03-31dCons.Equity IFRS
Equity (owners)¥827.5bnat 2023-09-30Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥640.1bnat 2023-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥643.0bnat 2022-09-30Cons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥488.2bnat 2023-09-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥169.3bnat 2023-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥205.5bnat 2023-03-31Cons.Cash and cash equivalents IFRS (5-year summary)
Cash & equivalents¥297.4bnat 2022-09-30Cons.Cash and cash equivalents IFRS (5-year summary)
Operating cash flow−¥11.8bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥98.5bn2022-04-01 → 2023-03-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥6.3bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in operating activities IFRS
Investing cash flow¥412.7bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥58.4bn2022-04-01 → 2023-03-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥15.7bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in investing activities IFRS
Financing cash flow−¥125.4bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥143.2bn2022-04-01 → 2023-03-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥35.5bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥173.812023-04-01 → 2023-09-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥-19.642023-07-01 → 2023-09-30dCons.Basic earnings loss per share IFRS
EPS (basic)¥113.222022-04-01 → 2023-03-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥52.52022-04-01 → 2022-09-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥32.972022-07-01 → 2022-09-30dCons.Basic earnings loss per share IFRS
EPS (diluted)¥173.432023-04-01 → 2023-09-30Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥-19.62023-07-01 → 2023-09-30dCons.Diluted earnings loss per share IFRS
EPS (diluted)¥113.082022-04-01 → 2023-03-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥52.452022-04-01 → 2022-09-30Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥32.932022-07-01 → 2022-09-30dCons.Diluted earnings loss per share IFRS
Equity ratio51.2%at 2023-09-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio42.4%at 2023-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio43.3%at 2022-09-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 10
SegmentItemPeriodValue
Reconciling Itemsreconcilingsegment profit2023-04-01 → 2023-09-30−¥18.6bn
jpcrp040300-q2r_E02272-000Endoscopic Solutionsreportable segmentsegment profit2023-04-01 → 2023-09-30¥50.9bn
jpcrp040300-q2r_E02272-000Otherreportable segmentsegment profit2023-04-01 → 2023-09-30¥1.0bn
jpcrp040300-q2r_E02272-000Therapeutic Solutionsreportable segmentsegment profit2023-04-01 → 2023-09-30−¥28.5bn
—segment totalsegment profit2023-04-01 → 2023-09-30¥23.4bn
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-09-30−¥4.3bn
jpcrp040300-q2r_E02272-000Endoscopic Solutionsreportable segmentsegment profit2022-04-01 → 2022-09-30¥68.9bn
jpcrp040300-q2r_E02272-000Otherreportable segmentsegment profit2022-04-01 → 2022-09-30−¥788m
jpcrp040300-q2r_E02272-000Therapeutic Solutionsreportable segmentsegment profit2022-04-01 → 2022-09-30¥29.8bn
—segment totalsegment profit2022-04-01 → 2022-09-30¥97.9bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 781
ItemContextValueUnit
Liabilities directly associated with assets held for sale IFRSCurrentQuarterInstant-JPY
Total current liabilities IFRSPrior1YearInstant461892000000JPY
Total current liabilities IFRSCurrentQuarterInstant423282000000JPY
Bonds and borrowings ncl IFRSPrior1YearInstant290087000000JPY
Bonds and borrowings ncl IFRSCurrentQuarterInstant248460000000JPY
Other financial liabilities ncl IFRSPrior1YearInstant61668000000JPY
Other financial liabilities ncl IFRSCurrentQuarterInstant61798000000JPY
Retirement benefit liability ncl IFRSPrior1YearInstant20416000000JPY
Retirement benefit liability ncl IFRSCurrentQuarterInstant21021000000JPY
Provisions ncl IFRSPrior1YearInstant2912000000JPY
Provisions ncl IFRSCurrentQuarterInstant2912000000JPY
Deferred tax liabilities IFRSPrior1YearInstant11905000000JPY
Deferred tax liabilities IFRSCurrentQuarterInstant13570000000JPY
Other non current liabilities ncl IFRSPrior1YearInstant18194000000JPY
Other non current liabilities ncl IFRSCurrentQuarterInstant19190000000JPY
Non current labilities IFRSPrior1YearInstant405182000000JPY
Non current labilities IFRSCurrentQuarterInstant366951000000JPY
Liabilities IFRSPrior1YearInstant867074000000JPY
Liabilities IFRSCurrentQuarterInstant790233000000JPY
Share capital IFRSPrior1YearInstant124643000000JPY
Share capital IFRSCurrentQuarterInstant124643000000JPY
Capital surplus IFRSPrior1YearInstant92150000000JPY
Capital surplus IFRSCurrentQuarterInstant91037000000JPY
Treasury shares IFRSPrior1YearInstant-28086000000JPY
Treasury shares IFRSCurrentQuarterInstant-90808000000JPY
Other components of equity IFRSPrior1YearInstant77280000000JPY
Other components of equity IFRSCurrentQuarterInstant135667000000JPY
Other components of capital related to the disposal group held for sale equity IFRSPrior1YearInstant3034000000JPY
Other components of capital related to the disposal group held for sale equity IFRSCurrentQuarterInstant-JPY
Retained earnings IFRSPrior1YearInstant371064000000JPY
Retained earnings IFRSCurrentQuarterInstant566993000000JPY
Equity attributable to owners of parent IFRSPrior1YearInstant640085000000JPY
Equity attributable to owners of parent IFRSCurrentQuarterInstant827532000000JPY
Non controlling interests IFRSPrior1YearInstant1149000000JPY
Non controlling interests IFRSCurrentQuarterInstant-JPY
Equity IFRSPrior1YearInstant641234000000JPY
Equity IFRSCurrentQuarterInstant827532000000JPY
Liabilities and equity IFRSPrior1YearInstant1508308000000JPY
Liabilities and equity IFRSCurrentQuarterInstant1617765000000JPY
Net sales IFRSPrior1YTDDuration417060000000JPY
Net sales IFRSCurrentYTDDuration436644000000JPY
Cost of sales IFRSPrior1YTDDuration139534000000JPY
Cost of sales IFRSCurrentYTDDuration148207000000JPY
Gross profit IFRSPrior1YTDDuration277526000000JPY
Gross profit IFRSCurrentYTDDuration288437000000JPY
Selling general and administrative expenses IFRSPrior1YTDDuration198535000000JPY
Selling general and administrative expenses IFRSCurrentYTDDuration221633000000JPY
Share of profit loss of investments accounted for using equity method IFRSPrior1YTDDuration371000000JPY
Share of profit loss of investments accounted for using equity method IFRSCurrentYTDDuration-234000000JPY
Other income IFRSPrior1YTDDuration19369000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-03-31pass
balance sheet identityconsolidated 2023-09-30pass
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-07-01/2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-09-30pass
statement vs summary · net income attributable to parentconsolidated 2023-07-01/2023-09-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-09-30pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-09-30pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-09-30pass